Production (Stage)
Health Discovery Corporation
HDVY
$0.00
$0.000.00%
OTC PK
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -100.00% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -100.00% | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -100.00% | -100.00% | -- | -- | -- |
| SG&A Expenses | 67.47% | 81.60% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.47% | 78.49% | -- | -- | -- |
| Operating Income | -67.59% | -78.63% | -- | -- | -- |
| Income Before Tax | -429.82% | -450.81% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -429.82% | -450.81% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -429.82% | -450.81% | -- | -- | -- |
| EBIT | -67.59% | -78.63% | -- | -- | -- |
| EBITDA | 84.18% | 63.37% | -- | -- | -- |
| EPS Basic | -373.33% | -312.50% | -- | -- | -- |
| Normalized Basic EPS | -483.33% | -414.29% | -- | -- | -- |
| EPS Diluted | -188.00% | -139.29% | -- | -- | -- |
| Normalized Diluted EPS | -250.00% | -227.27% | -- | -- | -- |
| Average Basic Shares Outstanding | 8.85% | 16.58% | -- | -- | -- |
| Average Diluted Shares Outstanding | 3.91% | 10.92% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |